Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 9—September 2005
Research

Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003

Pascal Lutumba*†, Jo Robays†, Constantin Miaka mia Bilenge*, Victor Kande Betu Ku Mesu*, Didier Molisho‡, Johan Declercq§, Wim Van der Veken§, Filip Meheus¶, Jean Jannin#, and Marleen Boelaert†Comments to Author 
Author affiliations: *Programme National de Lutte contre la Trypanosomiase Humaine Africaine, Kinshasa, Democratic Republic of Congo; †Institute of Tropical Medicine, Antwerp, Belgium; ‡Fonds Médical Tropical, Kinshasa, Democratic Republic of Congo; §Coopération Technique Belge, Kinshasa, Democratic Republic of Congo; ¶Institute of Development Policy and Management, Antwerp, Belgium; #World Health Organization, Geneva, Switzerland

Main Article

Table 2

Indicators for evaluating population screening for human African trypanosomiasis (HAT)*

Indicators
Input Financial resources
Human resources
Availability of tests and anti-HAT drugs
Process Identification of villages at risk
Census of population at risk
Involvement of population at risk in active case detection
Lymph node palpation
CATT test
Parasitologic test for HAT confirmation
Lumbar puncture to determine the stage of disease
Treatment
Treatment follow-up
Output Coverage rate of population at risk
Participation rate
Identification of suspects
Identification of HAT cases
Proportion of HAT cases detected and treated
Proportion of HAT cases treated and followed
Outcome Annual HAT detection rate and trend

*CATT, card agglutination test for trypanosomiasis; LN, lymph node palpation.

Main Article

Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external